Zealand Pharma at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
Zealand Pharma takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions cover peptide medicines for metabolic disease, from process development to translational research. With Bachem it traces dapiglutide from the lab to large-scale manufacture, and it also explores a selective amylin receptor agonist.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Zealand Pharma Søborg, Denmark | |
Danish biotech developing peptide medicines for obesity and metabolic diseases, including amylin and GLP-1 analogues. | Talk Wed Nov 4 16:15–16:45 Dapiglutide: From Lab to Large Scale Manufacture through Innovative Peptide Process Development How process changes in making the peptide drug dapiglutide raised its overall yield from about 20% to over 60%. Talk Fri Nov 6 10:30–10:55 |
Instantly find 20 buyers from Zealand Pharma
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction